(Q37121729)

English

Lower osteopontin plasma levels are associated with superior outcomes in advanced non-small-cell lung cancer patients receiving platinum-based chemotherapy: SWOG Study S0003

scientific article published on 08 September 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

18 August 2017

Lower osteopontin plasma levels are associated with superior outcomes in advanced non-small-cell lung cancer patients receiving platinum-based chemotherapy: SWOG Study S0003 (English)

1 reference

Europe PubMed Central

18 August 2017

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

David R Gandara

10

object named as

David R Gandara

1 reference

Europe PubMed Central

18 August 2017

author name string

Philip C Mack

1

1 reference

Europe PubMed Central

18 August 2017

Mary W Redman

2

1 reference

Europe PubMed Central

18 August 2017

Kari Chansky

3

1 reference

Europe PubMed Central

18 August 2017

Stephen K Williamson

4

1 reference

Europe PubMed Central

18 August 2017

Nichole C Farneth

5

1 reference

Europe PubMed Central

18 August 2017

Primo N Lara

6

1 reference

Europe PubMed Central

18 August 2017

Wilbur A Franklin

7

1 reference

Europe PubMed Central

18 August 2017

Quynh-Thu Le

8

1 reference

Europe PubMed Central

18 August 2017

John J Crowley

9

1 reference

Europe PubMed Central

18 August 2017

SWOG

11

1 reference

Europe PubMed Central

18 August 2017

language of work or name

0 references

publication date

8 September 2008

1 reference

Europe PubMed Central

18 August 2017

Journal of Clinical Oncology

1 reference

Europe PubMed Central

18 August 2017

26

1 reference

Europe PubMed Central

18 August 2017

29

1 reference

Europe PubMed Central

18 August 2017

4771-4776

1 reference

Europe PubMed Central

18 August 2017

The role of osteopontin in tumor progression and metastasis in breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653139

14 September 2017

Plasma osteopontin in comparison with bone markers as indicator of bone metastasis and survival outcome in patients with prostate cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653139

14 September 2017

The multifaceted roles of osteopontin in cell signaling, tumor progression and angiogenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653139

14 September 2017

Elevated plasma osteopontin associated with gastric cancer development, invasion and survival.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653139

14 September 2017

Monocyte/macrophage infiltration in tumors: modulators of angiogenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653139

14 September 2017

Hypoxia regulates macrophage functions in inflammation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653139

14 September 2017

Prognostic significance of osteopontin expression in early-stage non-small-cell lung cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653139

14 September 2017

Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small-cell lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653139

14 September 2017

Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653139

14 September 2017

Evidence for and against hypoxia as the primary cause of tumor aggressiveness.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653139

14 September 2017

Hypoxia-induced angiogenesis during carcinogenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653139

14 September 2017

Tumor angiogenesis of non-small cell lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653139

14 September 2017

Tirapazamine: prototype for a novel class of therapeutic agents targeting tumor hypoxia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653139

14 September 2017

Molecular-clinical correlative studies in non-small cell lung cancer: application of a three-tiered approach

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653139

14 September 2017

Cancer statistics, 2001

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653139

14 September 2017

The microenvironment of the tumour-host interface

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653139

14 September 2017

Hypoxia-Specific Cytotoxins in Cancer Therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653139

14 September 2017

Measurement of hypoxia in human tumours by non-invasive spect imaging of iodoazomycin arabinoside

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653139

14 September 2017

Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653139

14 September 2017

A biochemical characterization of the binding of osteopontin to integrins alpha v beta 1 and alpha v beta 5

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653139

14 September 2017

The adhesive and migratory effects of osteopontin are mediated via distinct cell surface integrins. Role of alpha v beta 3 in smooth muscle cell migration to osteopontin in vitro

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653139

14 September 2017

SR-4233: a new bioreductive agent with high selective toxicity for hypoxic mammalian cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653139

14 September 2017

Elevated expression of secreted phosphoprotein I (osteopontin, 2ar) as a consequence of neoplastic transformation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653139

14 September 2017

Expression and prognostic significance of a panel of tissue hypoxia markers in head-and-neck squamous cell carcinomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653139

14 September 2017

Human macrophages promote the motility and invasiveness of osteopontin-knockdown tumor cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653139

14 September 2017

Overexpression of osteopontin is associated with more aggressive phenotypes in human non-small cell lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653139

14 September 2017

Identification of osteopontin as a prognostic plasma marker for head and neck squamous cell carcinomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653139

14 September 2017

Differential osteopontin expression in lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653139

29 September 2017

Osteopontin induces increased invasiveness and plasminogen activator expression of human mammary epithelial cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653139

29 September 2017

Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653139

29 September 2017

The identification of osteopontin as a metastasis-related gene product in a rodent mammary tumour model

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653139

29 September 2017

Tirapazamine plus cisplatin versus cisplatin in advanced non-small-cell lung cancer: A report of the international CATAPULT I study group. Cisplatin and Tirapazamine in Subjects with Advanced Previously Untreated Non-Small-Cell Lung Tumors.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653139

27 June 2018

Candidate genes for the hypoxic tumor phenotype.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653139

27 June 2018

Induction of expression of osteopontin (OPN; secreted phosphoprotein) in metastatic, ras-transformed NIH 3T3 cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653139

27 June 2018

An evaluation of tumor oxygenation and gene expression in patients with early stage non-small cell lung cancers.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653139

3 September 2018

Phase III trial of paclitaxel plus carboplatin with or without tirapazamine in advanced non-small-cell lung cancer: Southwest Oncology Group Trial S0003.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653139

3 September 2018

Osteopontin but not osteonectin messenger RNA expression is a prognostic marker in curatively resected non-small cell lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653139

3 September 2018

In vivo assessment of tumor hypoxia in lung cancer with 60Cu-ATSM

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653139

3 September 2018

Involvement of hypoxia-inducible factor 1 in human cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653139

3 September 2018

Single agents in the second-line treatment of non-small cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18779603

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vascular endothelial growth factor and osteopontin in stage I lung adenocarcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/18779603

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CD44 variants but not CD44s cooperate with beta1-containing integrins to permit cells to bind to osteopontin independently of arginine-glycine-aspartic acid, thereby stimulating cell motility and chemotaxis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18779603

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical significance of osteopontin in esophageal squamous cell carcinoma: comparison with common tumor markers

1 reference

https://pubmed.ncbi.nlm.nih.gov/18779603

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serial Plasma Osteopontin Levels Have Prognostic Value in Metastatic Breast Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18779603

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Modification of the antitumor activity of chemotherapeutic drugs by the hypoxic cytotoxic agent tirapazamine

1 reference

https://pubmed.ncbi.nlm.nih.gov/18779603

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Asbestos exposure, pleural mesothelioma, and serum osteopontin levels

1 reference

https://pubmed.ncbi.nlm.nih.gov/18779603

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Elevated circulating level of osteopontin is associated with advanced disease state of non-small cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18779603

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of cancer chemotherapy on the hypoxic fraction of a solid tumor measured using a local tumor control assay

1 reference

https://pubmed.ncbi.nlm.nih.gov/18779603

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pancreatic tumors show high levels of hypoxia

1 reference

https://pubmed.ncbi.nlm.nih.gov/18779603

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical practice guidelines for the treatment of unresectable non-small-cell lung cancer. Adopted on May 16, 1997 by the American Society of Clinical Oncology

1 reference

https://pubmed.ncbi.nlm.nih.gov/18779603

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasma osteopontin is an independent prognostic marker for head and neck cancers

1 reference

https://pubmed.ncbi.nlm.nih.gov/18779603

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Osteopontin expression in lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18779603

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Elevated plasma osteopontin as marker for distant metastases and poor survival in patients with renal cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/18779603

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1200/JCO.2008.17.0662

1 reference

Europe PubMed Central

18 August 2017

1 reference

Europe PubMed Central

18 August 2017

1 reference

Europe PubMed Central

18 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37121729&oldid=2170234560"